Strategic Partnerships BRI maintains long-standing collaborations with GentiBio, SCRI, UW, and Virginia Mason Franciscan Health, signaling openness to co-development and translational research services across immunology and cell therapy, including study design, data sharing, and potential manufacturing partnerships.

Grant Funding Significant NIH funded programs and translational research initiatives indicate a stable project portfolio and ongoing demand for grant management, regulatory compliance, and sponsored research administration solutions.

Data Analytics The institute relies on biostatistics and data visualization tools and could benefit from an integrated analytics platform, secure data collaboration, and specialized statistical consulting to accelerate discovery.

IT Security With modern cloud and web tooling in use, there is an opportunity to deliver enterprise email security, data governance, cloud backup, and HIPAA-compliant collaboration services to support research operations.

Lab Therapies Active work on engineered regulatory T cells and partnerships with biotech companies point to demand for lab automation, GMP-grade supply chains, and contract research or manufacturing services to advance cell-therapy programs.